What is MDVLQ's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.00B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for MDVLQ?

P/E (TTM) is n/a and 52-week range is $0.00 to $0.05 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s MDVLQ figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for MDVLQ?

The company profile lists revenue (TTM) near $21M, net income (TTM) near -$4.11B, EPS (TTM) near -$28.24 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Medavail Holdings Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Phoenix, Arizona, US, 1.6M shares outstanding, ISIN US58406B2025 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Medavail Holdings Inc

$MDVLQ

Consumer Staples · Consumer Staples Distribution & Retail

IR Run Scenarios

Overview Charts AI Summary Financials Valuation

Profile

Read AI summary

MedAvail Holdings, Inc. is a pharmacy technology and services company, which engages in the development and commercialization of a self-service pharmacy, mobile application, and kiosk. The company is headquartered in Phoenix, Arizona and currently employs 279 full-time employees. The company went IPO on 2008-10-20. The firm is focused on developing and commercializing a self-service pharmacy, mobile application, and kiosk. Its core technology and product, the MedAvail MedCenter (the MedCenter), is a pharmacist-controlled, patient-interactive, prescription dispensing system akin to a pharmacy in a box. The company operates through two segments: Retail Pharmacy Services and Pharmacy Technology. The Retail Pharmacy Services segment operates as SpotRx, or the Pharmacy, which is a full-service retail pharmacy utilizing its automated pharmacy technology, primarily servicing Medicare patients in the United States. The Pharmacy Technology segment, through its MedAvail Technologies, Inc., develops and commercializes the MedCenter for direct sale or subscription to third-party customers, including some of the healthcare providers and systems, as well as large retail chains that provide full retail-pharmacy services using its technology.

Employees

279

Website

investors.medavail.com/overview/default.aspx

IPO

2008-10-20

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (price / listing EPS)

P/S (TTM)

Forward P/E

Forward P/S

EV / EBITDA

PEG (TTM)

FCF yield (TTM)

Gross margin (TTM)

Net margin (TTM)

Forward revenue growth (NTM)

Dividend / share (TTM)

Dividend yield (TTM)

Payout ratio (TTM)

Dividend growth (5Y)

Company context

Exchange

OTC MARKETS

ISIN

US58406B2025

Headquarters

Phoenix, Arizona, US

Shares outstanding

1.6M

NAICS sector

Manufacturing

Institutional ownership

0.00%

Browse other companiesFree AI scores and summaries for more stocks